These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7339803)

  • 21. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
    Kuze F
    Am Rev Respir Dis; 1984 Mar; 129(3):453-9. PubMed ID: 6703503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parotitis due to Mycobacterium and HIV infection].
    Benharrats I; Jacob L; Taulera O
    Rev Med Interne; 1998 Sep; 19(9):676-7. PubMed ID: 9793160
    [No Abstract]   [Full Text] [Related]  

  • 25. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
    Levine B; Chaisson RE
    Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical analysis of 96 cases with pulmonary disease caused by nontuberculous mycobacteria].
    Xia X; Gui X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):239-41. PubMed ID: 11775923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary infection with nontuberculous mycobacteria.
    Contreras MA; Cheung OT; Sanders DE; Goldstein RS
    Am Rev Respir Dis; 1988 Jan; 137(1):149-52. PubMed ID: 3337456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patients.
    Andréjak C; Lescure FX; Douadi Y; Laurans G; Smail A; Duhaut P; Jounieaux V; Schmit JL
    J Infect; 2007 Jul; 55(1):34-40. PubMed ID: 17360040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.
    Philley JV; Wallace RJ; Benwill JL; Taskar V; Brown-Elliott BA; Thakkar F; Aksamit TR; Griffith DE
    Chest; 2015 Aug; 148(2):499-506. PubMed ID: 25675393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical mycobacterial infections: a clinical study of 92 patients.
    Kim TC; Arora NS; Aldrich TK; Rochester DF
    South Med J; 1981 Nov; 74(11):1304-8. PubMed ID: 7302627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
    Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
    Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary disease due to atypical mycobacteria: a retrospective study from South India.
    Ramakrishnan CV
    Rev Infect Dis; 1981; 3(5):1090-2. PubMed ID: 7339810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-course chemotherapy for mycobacteriosis kansasii?
    Schraufnagel DE; Leech JA; Schraufnagel MN; Pollak B
    Can Med Assoc J; 1984 Jan; 130(1):34-8. PubMed ID: 6418368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifabutin in the treatment of cavitary lung disease due to Mycobacterium gordonae.
    Nathan V; Mehta JB; Dralle W
    South Med J; 1993 Jul; 86(7):839-41. PubMed ID: 8391724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course.
    Nei T; Saitoh T; Morimoto K; Watanabe K; Hayashihara K; Azuma A; Kudoh S
    J Infect Chemother; 2007 Oct; 13(5):343-5. PubMed ID: 17982725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada.
    Damaraju D; Jamieson F; Chedore P; Marras TK
    Int J Tuberc Lung Dis; 2013 May; 17(5):676-81. PubMed ID: 23575335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y; Oka M
    Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterial infections in renal allograft recipients.
    Spence RK; Dafoe DC; Rabin G; Grossman RA; Naji A; Barker CF; Perloff LJ
    Arch Surg; 1983 Mar; 118(3):356-9. PubMed ID: 6337585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary disease due to Mycobacterium massiliense.
    Mitra S; Tapadar SR; Banerjee D; Bhattacharjee S; Dey S; Kundu S
    Indian J Chest Dis Allied Sci; 2012; 54(1):53-7. PubMed ID: 22779125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.